Antifungal Drugs in Pulmonary Mucormycosis

NCT06756191 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Mucormycosis

Interventions

DRUG: Combination therapy group
DRUG: Liposomal Amphotericin B

Sponsor

Bin Cao